Piraye Beim

Dr. Piraye Yurttas Beim, PhD is the founder and former CEO of Celmatix. She recently led the successful sale of Celmatix’s therapeutic pipeline to Gedeon Richter, advancing multiple first-in-class programs in ovarian health, fertility, and endometriosis. Founded in 2009 as one of the first FemTech companies, Celmatix’s mission was to accelerate precision medicine in women’s health. Under Dr. Beim’s leadership, Celmatix was recognized as one of Fast Company’s Most Innovative Companies and pioneered breakthroughs in decoding the genomic drivers of ovarian function and unlocking unprecedented insight into unique aspects of female biology and health. Dr. Beim’s publications have been widely cited, and she has been the primary inventor of many of Celmatix’s disruptive innovations, including groundbreaking drug programs for improving and extending ovarian function. Her work was supported by a prestigious ARPA-H award as part of the US Sprint for Women’s health and has helped establish ovarian aging as a central frontier in longevity science and positioned female biology as a critical foundation for the future of precision medicine. Dr. Beim has dedicated herself to innovating in women’s health for more than 25 years. During her PhD work at Cornell University (Weill, NYC) and Memorial Sloan Kettering Cancer Center, she was on the front lines of the precision medicine revolution in oncology. She then completed her post-doc at the University of Cambridge (UK), focusing on the science of fertility. Dr. Beim is also the founder and chair of Eve’s Ark, a nonprofit dedicated to accelerating innovation in women’s health by building the data, infrastructure, and collaborative frameworks needed to fully integrate female biology into modern medicine and AI-driven discovery. Through Eve’s Ark, she is working to address systemic bottlenecks in research and ensure that insights from female biology benefit all of human health. Dr. Beim is also widely recognized as a notable business leader and entrepreneur. She is a member of the Aspen Global Leadership Network, was named to Elle Magazine’s “Women in Tech” Power List, Inc Magazine’s 2025 Top Female Founders, Crain’s 40 Under 40 and its Notable Women in Tech, Goldman Sachs’s Most Intriguing Entrepreneurs, Top 15 founders disrupting their industries by Fortune, and Rock Health’s Disruptive Founder of the Year. She is also on the boards of the Center on Rural Innovation and Eve’s Ark, where she serves as Chair. She is an active angel investor, podcaster (the Boss Ovary Podcast), and lives between New York City and Bridgehampton with her three children. She doesn’t intend to go into menopause, ever.

All things science, including women’s health and longevity.

We Can End Menopause

writing poetry